Will AstraZeneca's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by May 1, 2021?

What are the current odds?

Based on Polymarket prediction data, the current odds are:

Trading volume: $29.1k | Status: Closed

What do we know about this question?

This is a market on whether AstraZeneca’s COVID-19 vaccine will receive regulatory approval in the USA in the form of either FDA approval OR Emergency Use Authorization, whichever comes first. This market will resolve to “Yes” if AstraZeneca’s COVID-19 vaccine receives FDA approval or EUA prior to the resolution date, May 1, 2021, 12:00 PM ET, and "No" otherwise. This market will be resolved in good faith, according to the FDA list of licensed vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), the FDA EUA list (https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization), as well as any other resolution source deemed appropriate by the Markets Integrity Committee (MIC).

What are experts predicting?

Whale traders with large portfolios are actively trading this market on Polymarket. These high-volume traders often have access to deep research and move prices when they take positions. Track which wallets are placing large bets on this question and follow their conviction using PredCopy.